Skip to main content
  • Glioblastoma stem cell-driven recurrence radically changes tumor physiology, microenvironment and drug delivery via Gaussian shift.

    Final Number:

    Peter C Warnke MD; Sean Polster; Christoph B. Ostertag; Klaus Kopitzki MA

    Study Design:
    Clinical Trial

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2014 Annual Meeting

    Introduction: Recurrent glioblastomas are highly resistant to treatment due to repopulation with glioma stem cells. We wanted to investigate whether these highly resistant cells also induce a vascular and extacellular microenvironment that contribute to therapeutic resistance

    Methods: We have studied 7 GBMs before treatment and after recurrence. All patients underwent three-dimensional measurements of bidirectional capillary permeability, vascular volume , extracellular space and regional tumor blood flow before and after standard treatment. In addition a serial stereotactic biopsy was performed at recurrence to assess the glioma stem cell density. The physiological images were stereotactically coregistered with the biopsy sites to correlate physiological values with stem cell density.

    Results: Capillary permeability was significantly increased from 23.9 +12.4 to 47.7+11.5 microl/g/min (p<0.01) and so was the size of the extracellular space (0.21 to 0.38.2 ml/g) in recurrent tumors (p<0.01). Blood flow was reduced from 43.3 +6.7 to 21.9+4.8 ml/g/min (p<0.01) almost reaching hypoxic tresholds. Histogram analysis of voxel distribution of physiological parameters showed that pretreatment values showed a Gaussian distribution whereas in recurrent tumors a complete shift towards extreme shoulders occur with for example higher K1 values and lower k2 values signifying a massive enlargement of extracellular space. Coregistration with biopsy sites showed that physiological variables were shifted the most towards excessive values in the vicinity of high density of glioma stem cells ( Correlation coefficient r=0.76, p<0.001)

    Conclusions: Glioma stem cells create a physiological niche around them characterized by large extracellular space and high permeability resulting in high interstitial pressure and low perfusion and hypoxia which form the physiological substrate of therapeutic resistance in human tumors.

    Patient Care: Individualize drug delivery to recurrent GBM and design individually tailored convection protocols to target stem cell niches.

    Learning Objectives: To understand the contribution of tumor physiology in glioma stem cell driven tumor recurrence.


We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy